ThursdayJan 23, 2020 9:00 am

How CBD Combats Inflammation

Have you been paying attention to the news recently? If you have, you'll undoubtedly have heard of cannabidiol or CBD. It’s a chemical extracted from the hemp plant, and going by the anecdotal evidence and some research findings, it's a potent and versatile medicine. Users claim cannabidiol gave them relief from a plethora of conditions, ranging from high blood pressure and chronic pain to anxiety and insomnia. Last year, the FDA approved a CBD-derived drug to treat seizures caused by two rare and hard to treat pediatric epilepsies, Dravet Syndrome and Lennox-Gastaut Syndrome. Also, a recent poll by Gallup found…

Continue Reading

WednesdayJan 22, 2020 4:00 pm

FDA-Approved Cannabis Drug Rakes in $296 Million in First Year of Sales

Cannabidiol is a chemical that's extracted from the hemp plant, and it has taken the world by storm. While people often confuse hemp with its illicit cousin marijuana, they differ in one critical way. The 2018 Farm Bill legalized industrial hemp, defining it as cannabis with less than 0.3% THC. It is the chemical responsible for marijuana's psychoactive high. CBD takes the cake in other ways. Said to be chock-full of medicinal properties, it is used to help manage a variety of ailments, ranging from chronic pain and high blood pressure to anxiety. Unfortunately, there's limited scientific evidence to back…

Continue Reading

WednesdayJan 22, 2020 12:40 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Inks Licensing Deal with Smokeless Cannadips CBD Product Maker

Lexaria Bioscience is a company dedicated to developing effective oral ingestion methods for drug substances that rival the rapid-delivery qualities of more health-dangerous inhaled-drug products. Inhalation is a particularly popular method of using tobacco and cannabis products, despite government warnings about the scientifically established dangers of doing so Lexaria has been boosting its profile and revenue potential through licensing agreements with other companies Lexaria recently announced a licensing agreement with Cannadips CBD-maker The Boldt Runners Corporation The agreement grants Cannadips CBD use of Lexaria’s DehydraTECH IP to improve the speed of its effectiveness and to combat the throat irritation that…

Continue Reading

WednesdayJan 22, 2020 9:00 am

Carlos Santana Announces Plans to Launch CBD Brands in 2020

Cannabidiol, or CBD, has been having a fantastic run for the last few years. For something that was barely known three or so years ago, it has grown into an industry worth millions of dollars, and experts say it may hit $20 billion by 2020. It's quickly losing its fringe product status and moving into the mainstream, as evidenced by the mountains of anecdotal evidence detailing its diverse medical abilities. Forward-thinking CBD and hemp brands have partnered with celebrities to get even more exposure, while other celebrities have jumped onto the bandwagon themselves, pulling their sleeves up and joining the…

Continue Reading

TuesdayJan 21, 2020 4:00 pm

New Study Shows CBD Can Ease Public Speaking Anxiety

Unless you've been living under a rock for the past few years, you have undoubtedly heard about cannabidiol (CBD), or maybe even tried it. The hemp extract has been having a fantastic run, with new testimonials on its benefits coming to light almost every day, accompanied by a government that seems interested in furthering research into the compound. The chemical is said to be a potent natural medicine, able to act against a variety of ailments ranging from high blood pressure and chronic pain to anxiety. In fact, a survey by Gallup found that a large number of Americans who…

Continue Reading

TuesdayJan 21, 2020 12:21 pm

MCTC Holdings Inc. (MCTC) Announces Drive to Make THC-V Extract Useful at Nanoparticle Levels

MCTC Holdings Inc. (soon to become Cannabis Global Inc.) is a cannabis science innovator working to develop marketable infusion technologies based on the premise of cannabinoid extract efficiency at extremely low quantities MCTC recently announced the launch of Project Varin, an effort to develop nanoparticle and nano fiber expressions of ultra-rare tetrahydrocannabivarin (THC-V) and to make those useful biologically at such extremely small levels The company also plans to develop the rare cannabinol (CBN) extract by the same means MCTC recently announced a new revenue stream through an infused coffee product under its Hemp You Can Feel label Visionary cannabinoid…

Continue Reading

TuesdayJan 21, 2020 9:00 am

Could Smoking CBD Relieve Flu Symptoms?

It's hard to believe that as civilized as we are, and with all the advancements we've made, a silly little flu will curse you to a week of intense discomfort. While there are tons of over the counter medications designed to make the ordeal more bearable, you have to let the infection run its course. And more often than not, it's an extremely sucky experience. Enter cannabidiol or CBD. It is extracted from hemp, and according to anecdotal evidence, it is an extremely potent and versatile natural medicine. It is said to be effective against a range of illnesses, including…

Continue Reading

FridayJan 17, 2020 4:00 pm

Bipartisan Bill Seeks to Compel FDA to Regulate CBD as Dietary Supplement

The new decade brings good tidings for the budding hemp/CBD sector. A bipartisan coalition of lawmakers has introduced a bill that would allow sellers to market hemp-derived CBD as a dietary supplement. The 2018 Farm Bill legalized industrial hemp, classifying cannabis with less than 0.3% THC as legal hemp. Thus hemp and its extracts, including CBD, could be marketed and sold legally. The THC limit, however, was the extent of regulation the sector received. Apart from that, sellers had no rules to go by, and by the time the FDA was taking notice, the sector was booming, with experts estimating…

Continue Reading

FridayJan 17, 2020 1:40 pm

ChineseInvestors.com Inc. (CIIX) to Market CBD, Build Sales through Social Media Strategies

CIIX CEO said company will employ social media as it markets new CBD products starting March 2020 CIIX subsidiary CBD Biotech Co. focused on driving growth, building online sales to younger demographics in China Goals of CIIX strategy include profitability, expansion of market, maximized impact ChineseInvestors.com Inc. (OTCQB: CIIX) CEO Warren Wang said the company will adopt social media multiplatform techniques to market new CBD products beginning in March 2020. The move is designed to boost online sales to a younger demographic in China through its subsidiary CBD Biotech, explained Wang during a MoneyTV interview with host Donald Baillargeon. In…

Continue Reading

FridayJan 17, 2020 12:10 pm

Emerald Organic Products Inc. (EMOR) Merges with Health and Wellness Leader, Sets Sights on Global CBD Market Penetration

Merger with Pura Vida Health seen as mutually beneficial for both players in the CBD health and wellness space EMOR’s Pura Vida business plan allows the company to achieve full vertical integration The company promises quality control of CBD product offerings, from seed to shelf Emerald Organic Products Inc. (OTC: EMOR), a diversified cannabidiol (CBD)-focused health sciences company, recently announced the completion of a definitive plan to merge with Pura Vida Health LLC, a health and wellness company focused on using natural ingredients – including the increasingly desired CBD – to help customers achieve optimal health. This mutually beneficial merger…

Continue Reading

CBDWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000